Skip to content

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

  • Home
  • About US
  • Bioinsight
  • Policy Hub
  • Deals Book
  • Privacy Policy
  • Contact US

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

Company Deals

InSilico Medicine Debuts on HKEX in $2.3B IPO, Valuing AI Drug Platform at $1.5B

Fineline Cube Dec 18, 2025
Company Deals

Sirnaomics Partners on $42M Small Nucleic Acid Fund in Hangzhou

Fineline Cube Dec 18, 2025
Company Deals

HBM BMS Multi-Specific Antibody Deal Targets $1 Billion Milestones

Fineline Cube Dec 18, 2025
Company Deals

Sanofi Adel Alzheimer’s Deal Targets Phase 1 ADEL-Y01 Antibody

Fineline Cube Dec 18, 2025
Company Deals

Byterna Therapeutics Raises Angel Plus Round for cmRNA CAR‑T Pipeline

Fineline Cube Dec 17, 2025
Policy / Regulatory

China Mandates Specialty Departments in Primary Care by 2030

Fineline Cube Dec 18, 2025
Company Drug

Grand Pharmaceutical RDC GPN01530 Wins FDA Phase I/II Nod for FAP Tumor Diagnosis

Fineline Cube Dec 18, 2025
Company Drug

DualityBio’s DB-1310 Wins FTD as First HER3‑ADC for HR+/HER2‑ Breast Cancer

Fineline Cube Dec 18, 2025
Company Deals

Xellsmart Raises RMB 200M in Series A1 Round for Stem-Cell Therapies

Fineline Cube Nov 8, 2022

Xellsmart, a stem-cell startup based in Suzhou, has reportedly raised over RMB 200 million (USD...

Company

Novo Nordisk Reports 16% YOY Growth in Q3, Raises Full-Year Guidance

Fineline Cube Nov 8, 2022

Denmark-based biopharma Novo Nordisk A/S (NYSE: NVO) has released its Q3 2022 earnings report. The...

Company Deals

Novo Nordisk Partners with Shanghai Pharma for Smart Logistics at CIIE

Fineline Cube Nov 8, 2022

Novo Nordisk (NYSE: NVO) has announced a strategic partnership with China’s Shanghai Pharmaceuticals (HKG: 2607,...

Company Deals

SIMR Biotechnology Raises RMB 150M in Series C1 Financing Round

Fineline Cube Nov 8, 2022

China’s Shanghai SIMR Biotechnology Co., Ltd has reportedly raised RMB 150 million (USD 20.7 million)...

Company Deals Digital

PingAn Good Doctor Partners with Roche and OrigiMed at CIIE

Fineline Cube Nov 8, 2022

The 5th China International Import Expo (CIIE) saw China-based Ping An Healthcare and Technology Co.,...

Company Deals Digital

Organon Partners with Alibaba Health to Enhance Chronic Disease Management

Fineline Cube Nov 8, 2022

Organon & Co. (NYSE: OGN), a firm with a strong focus on women’s health that...

Company Drug

Qilu Pharma’s QL1706 Shows Promise in Phase II Cervical Cancer Study

Fineline Cube Nov 8, 2022

China-based Qilu Pharmaceutical has published the latest results from a Phase II clinical study for...

Company Deals

Organon Sponsors Retail Pharmacy Health Center at CIIE

Fineline Cube Nov 8, 2022

The 5th China International Import Expo (CIIE) saw Organon & Co. (NYSE: OGN), a firm...

Company Deals

Sanofi Partners with China Resources Sanjiu at CIIE for Consumer Healthcare

Fineline Cube Nov 8, 2022

The 5th China International Import Expo (CIIE) saw Sanofi’s consumer healthcare unit announce a partnership...

Company Deals

Sumitomo Dainippon Partners with Profex to Promote Antipsychotics in China

Fineline Cube Nov 8, 2022

Japan-based Sumitomo Dainippon Pharma Co., Ltd has announced a partnership with Profex, a trade company...

Company Deals

Eli Lilly Partners with AmoyDx and Burning Rock for Retevmo Companion Diagnostics

Fineline Cube Nov 7, 2022

The 5th China International Import Expo (CIIE) saw US-based Eli Lilly (NYSE: LLY) announce a...

Company

BioNTech’s Comirnaty Gets Limited Authorization in China Amid Scholz Visit

Fineline Cube Nov 7, 2022

Germany-based mRNA specialist BioNTech (NASDAQ: BNTX) reportedly benefited from German Chancellor Olaf Scholz’s visit to...

Company

Organon’s Q3 Results Show Women’s Health Segment Outperforms Amid Global Revenue Decline

Fineline Cube Nov 7, 2022

US-based Organon & Co. (NYSE: OGN), a firm with a strong focus on women’s health...

Company Deals

Organon Signs MOU with China’s National Health Commission at CIIE

Fineline Cube Nov 7, 2022

Organon & Co. (NYSE: OGN), a firm with a strong focus on women’s health that...

Company Drug

Ascletis Pharma Presents Phase I Study Results for ASC43F at AASLD

Fineline Cube Nov 7, 2022

China-based Ascletis Pharma Inc. (HKG: 1672) made a poster presentation detailing the abstract of a...

Company Drug

Ji Xing Pharmaceuticals’ Omecamtiv Mecarbil Accepted for Review by CDE

Fineline Cube Nov 7, 2022

Shanghai-based Ji Xing Pharmaceuticals, backed by RTW Investments, announced that a market filing for its...

Company Deals

Sophway Raises ‘Tens of Millions’ in Angel Round for Endoscope Development

Fineline Cube Nov 7, 2022

Sophway Technology, a full HD endoscope system developer based in Shenzhen, has reportedly raised “tens...

Company Deals

CIIE: MET HER2 Precision Diagnosis Alliance Formed to Advance Lung Cancer Treatment

Fineline Cube Nov 7, 2022

The 5th China International Import Expo (CIIE) witnessed the establishment of the MET HER2 precision...

Company Deals

CIIE: Bo’ao Lecheng Zone Announces Partnerships with Multinationals

Fineline Cube Nov 7, 2022

The 5th China International Import Expo (CIIE) saw the Bo’ao Lecheng Medical Tourism Pilot Zone...

Company

Cytiva Announces RMB 60M Investment for China Science Innovation Center at CIIE

Fineline Cube Nov 7, 2022

Cytiva—formerly GE Healthcare Life Sciences and now the life science platform of Danaher Corporation—announced at...

Posts pagination

1 … 538 539 540 … 599

Recent updates

  • Grand Pharmaceutical RDC GPN01530 Wins FDA Phase I/II Nod for FAP Tumor Diagnosis
  • DualityBio’s DB-1310 Wins FTD as First HER3‑ADC for HR+/HER2‑ Breast Cancer
  • Yabao’s GLX002 Wins NMPA Approval for PAH Clinical Trial, First Modified Bosentan
  • Biostar Technologies Doses First Patient in US Pivotal Trial for Utedelone in Breast Cancer Brain Mets
  • Asieris’ APL-2401 FGFR2/3 Inhibitor Wins NMPA Nod for Phase 1 Solid Tumor Trial
Special Report 2025 Q1: U.S. Targets Chinese Pharma with 200% Tariffs—Will the Global Drug Market Collapse?

Category

  • Company
  • Deals
  • Digital
  • Drug
  • General/Other
  • Hospital
  • Legal / IP
  • Medical Device
  • Others
  • Policy / Regulatory
  • R&D

You Missed

Company Drug

Grand Pharmaceutical RDC GPN01530 Wins FDA Phase I/II Nod for FAP Tumor Diagnosis

Company Drug

DualityBio’s DB-1310 Wins FTD as First HER3‑ADC for HR+/HER2‑ Breast Cancer

Company Drug

Yabao’s GLX002 Wins NMPA Approval for PAH Clinical Trial, First Modified Bosentan

Company Drug

Biostar Technologies Doses First Patient in US Pivotal Trial for Utedelone in Breast Cancer Brain Mets

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

Copyright © 2025 | Fineline Information & Technology | BlogData by Themeansar.